Chief Brexit negotiators suspend talks after Covid hits aide

Published Thu, Nov 19, 2020 · 03:40 PM

[BRUSSELS] Crunch talks over a post-Brexit trade agreement were disrupted on Thursday when one European Union official involved in the negotiations tested positive for the coronavirus.

Michel Barnier, the EU's chief Brexit negotiator, said in a tweet that he would suspend talks with his UK counterpart David Frost "for a short period." Mr Barnier added, however, that the two teams will continue their work "in full respect of guidelines."

It's unclear how the interruption will affect the deliberations just 41 days before the end of the post-Brexit transition period. The two sides are trying to reach an agreement by early next week to allow time for any accord to be ratified before year-end.

One senior EU official said on Wednesday that the two sides had yet to bridge their differences over fishing, the level playing field for businesses and the governance of a potential trade agreement. Mr Barnier was scheduled to brief EU government envoys in Brussels about the state of the talks on Friday morning.

This isn't the first time the coronavirus has disrupted the negotiations. In March, Mr Barnier, Mr Frost and several members of their teams were forced into isolation after either testing positive for, or showing symptoms of, Covid. The two sides were also forced to suspend face-to-face discussions as Europe went into a continent-wide lockdown.

"The health of our teams comes first," Mr Frost said in a tweet, adding that he is in close contact with Mr Barnier about the situation.

GET BT IN YOUR INBOX DAILY

Start and end each day with the latest news stories and analyses delivered straight to your inbox.

VIEW ALL

BLOOMBERG

KEYWORDS IN THIS ARTICLE

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

International

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here